Relmada Therapeutics, Inc. RLMD Deferred Tax Assets
Deferred Tax Assets at other companies
Other financials
Where this comes from
Reported directly by Relmada Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:DeferredTaxAssetsOther.
The official record: Relmada Therapeutics, Inc.’s 10-K, filed March 19, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relmada Therapeutics, Inc.'s deferred tax assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relmada Therapeutics, Inc.'s deferred tax assets?
- Relmada Therapeutics, Inc. (RLMD) reported deferred tax assets of $11K in Q4 2025.
- How has Relmada Therapeutics, Inc.'s deferred tax assets changed year-over-year?
- Relmada Therapeutics, Inc.'s deferred tax assets decreased by 0.0% year-over-year, from $11K to $11K.
- What is the long-term trend for Relmada Therapeutics, Inc.'s deferred tax assets?
- Over 5 years (2020 to 2025), Relmada Therapeutics, Inc.'s deferred tax assets has grown at a -76.2% compound annual growth rate (CAGR), from $14.39M to $11K.
- What does deferred tax assets mean?
- Future tax benefits from temporary differences, net operating loss carryforwards, and tax credit carryforwards that will reduce future tax payments.